Clinical Trials in Cleveland

Showing 4161-4180 of 19,775 trials

Kaneka Endovascular Embolization and Protection

NCT05563051

Prospective, multi-center, non-randomized registry / study, up to 164 patients enrolled and followed at 180 days +/- 45 days and again at 365 days +/- 90 days post procedure

Aneurysm Cerebral

Kaneka Medical America LLC164 participantsStarted Dec 2022

Grand Blanc, Michigan, United States • New York, New York, United States • Cleveland, Ohio, United States +1 more locations

Active Not RecruitingNA< 1 mile

P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation

NCT03438747

The aim of this trial is to evaluate if P-15L bone graft (investigational device) is not inferior in effectiveness and safety to local autologous bone (and allograft where necessary) as an extender (control device) when applied in instrumented transforaminal lumbar interbody fusion (TLIF) in subjects with degenerative disc disease (DDD). In addition to the general overall objective, a sub-group analysis will be performed on the high-risk subject population (tobacco use, obesity, diabetes), as previous studies have shown negative effects of smoking, obesity and diabetes on fusion and bone healing, increased peri/postoperative complications, and lower patient-reported outcome scores.

Degenerative Disc Disease

CeraPedics, Inc290 participantsStarted Apr 2018

Birmingham, Alabama, United States • Glendale, California, United States • Los Angeles, California, United States +31 more locations

Kaneka Endovascular Embolization and Protection

P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation

Find Trials by Condition in Cleveland

Glycemic Control, Type II Diabetes, Parathyroidectomy

Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant

EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction

Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)

Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate Cancer

Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension

Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria

Safety and Efficacy Trial of MTX101 2mg for the Acute Treatment of Migraine in Adults

Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD

Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2

Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others

The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)

A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy

Rollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study Treatments

Acquired Dyslexia Modeling and Treatment

Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection